Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer

Gastroenterology

Volumn 144, Issue 5, 2013, Pages 1098-1106

  Cappello, Paola ^a   Rolla, Simona ^a   Chiarle, Roberto ^a   Principe, Moitza ^a   Cavallo, Federica ^a   Perconti, Giovanni ^b,c   Feo, Salvatore ^b,c   Giovarelli, Mirella ^a   Novelli, Francesco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c CNR   (Italy)

Author keywords

Antitumor Immunity; IFN ; Immunotherapy; Th17

Indexed keywords

ALPHA ENOLASE; CANCER VACCINE; DNA VACCINE; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELLULAR IMMUNITY; COMPLEMENT DEPENDENT CYTOTOXICITY; CYTOTOXICITY; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENETIC ENGINEERING; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SURVIVAL TIME; TH1 CELL; TH17 CELL; TUMOR IMMUNITY;

EID: 84876475880     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.01.020     Document Type: Article

References (41)

1. A. Jemal, R. Siegel, E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96
2. N. Omura, M. Goggins Epigenetics and epigenetic alterations in pancreatic cancer Int J Clin Exp Pathol 2 2009 310 326
3. B. Tomaino, P. Cappello, M. Capello Autoantibody signature in human ductal pancreatic adenocarcinoma J Proteome Res 6 2007 4025 4031
4. B. Tomaino, P. Cappello, M. Capello Circulating autoantibodies to phosphorylated alpha-enolase are a hallmark of pancreatic cancer J Proteome Res 10 2011 105 112
5. P. Cappello, B. Tomaino, R. Chiarle An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen Int J Cancer 125 2009 639 648
6. M. Capello, S. Ferri-Borgogno, P. Cappello α-enolase: a promising therapeutic and diagnostic tumor target FEBS J 278 2011 1064 1074
7. V. Pancholi Multifunctional alpha-enolase: its role in diseases Cell Mol Life Sci 58 2001 902 920
8. S.R. Hingorani, E.F. Petricoin, A. Maitra Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Cancer Cell 4 2003 437 450
9. R.H. Hruban, N.V. Adsay, J. Albores-Saavedra Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations Cancer Res 66 2006 95 106
10. A. Giallongo, S. Feo, R. Moore Molecular cloning and nucleotide sequence of a full-length cDNA for human alpha enolase Proc Natl Acad Sci U S A 83 1986 6741 6745
11. M. Giovarelli, P. Cappello, G. Forni Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes J Immunol 164 2000 3200 3206
12. C.E. Clark, S.R. Hingorani, R. Mick Dynamics of the immune reaction to pancreatic cancer from inception to invasion Cancer Res 67 2007 9518 9527
13. G.J. Martinez, R.I. Nurieva, X.O. Yang Regulation and function of proinflammatory TH17 cells Ann N Y Acad Sci 1143 2008 188 211
14. I. Kryczek, M. Banerjee, P. Cheng Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments Blood 114 2009 1141 1149
15. D. Laheru, E.M. Jaffee Immunotherapy for pancreatic cancer - science driving clinical progress Nat Rev Cancer 5 2005 459 467
16. S.R. Hingorani, L. Wang, A.S. Multani Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice Cancer Cell 7 2005 469 483
17. L.M. Weiner, J.C. Murray, C.W. Shuptrine Antibody-based immunotherapy of cancer Cell 148 2012 1081 1084
18. C.W. Shuptrine, R. Surana, L.M. Weiner Monoclonal antibodies for the treatment of cancer Semin Cancer Biol 22 2012 3 13
19. M. Mitsdoerffer, Y. Lee, A. Jager Proinflammatory T helper type 17 cells are effective B-cell helpers Proc Natl Acad Sci U S A 107 2010 14292 14297
20. J. Hasbold, J.S. Hong, M.R. Kehry Integrating signals from IFN-gamma and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a J Immunol 163 1999 4175 4181
21. K. Guo, J. Li, J.P. Tang Targeting intracellular oncoproteins with antibody therapy or vaccination Sci Transl Med 3 2011 99ra85
22. R. Lopez-Alemany, C. Longstaff, S. Hawley Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-enolase Am J Hematol 72 2003 234 242
23. M. Wygrecka, L.M. Marsh, R.E. Morty Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung Blood 113 2009 5588 5598
24. J.L. Gnerlich, J.B. Mitchem, J.S. Weir Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer J Immunol 185 2010 4063 4071
25. K. Fujita, C.M. Ewing, L.J. Sokoll Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation Prostate 68 2008 872 882
26. M. DuPage, A.F. Cheung, C. Mazumdar Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression Cancer Cell 19 2011 72 85
27. L.W. Weber, W.B. Bowne, J.D. Wolchok Tumor immunity and autoimmunity induced by immunization with homologous DNA J Clin Invest 102 1998 1258 1264
28. W.B. Bowne, R. Srinivasan, J.D. Wolchok Coupling and uncoupling of tumor immunity and autoimmunity J Exp Med 190 1999 1717 1722
29. W.W. Overwijk, A. Tsung, K.R. Irvine gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand J Exp Med 188 1998 277 286
30. J. Li, M.Y. Merl, J. Chabot Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting." Chicago, IL, USA. June 4-8, 2010 JOP 11 2010 310 312
31. I. Kryczek, S. Wei, W. Szeliga Endogenous IL-17 contributes to reduced tumor growth and metastasis Blood 114 2009 357 359
32. N. Martin-Orozco, P. Muranski, Y. Chung T helper 17 cells promote cytotoxic T cell activation in tumor immunity Immunity 31 2009 787 798
33. W. Zou, N.P. Restifo T(H)17 cells in tumour immunity and immunotherapy Nat Rev Immunol 10 2010 248 256
34. L. Zitvogel, L. Apetoh, F. Ghiringhelli Immunological aspects of cancer chemotherapy Nat Rev Immunol 8 2008 59 73
35. G. Kroemer, L. Zitvogel Death, danger, and immunity: an infernal trio Immunol Rev 220 2007 5 7
36. E. Suzuki, V. Kapoor, A.S. Jassar Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity Clin Cancer Res 11 2005 6713 6721
37. H.J. Ko, Y.J. Kim, Y.S. Kim A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model Cancer Res 67 2007 7477 7486
38. C.M. Diaz-Montero, M.L. Salem, M.I. Nishimura Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy Cancer Immunol Immunother 58 2009 49 59
39. D.I. Gabrilovich, S. Nagaraj Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 9 2009 162 174
40. A. Sistigu, S. Viaud, N. Chaput Immunomodulatory effects of cyclophosphamide and implementations for vaccine design Semin Immunopathol 33 2011 369 383
41. M. Kraman, P.J. Bambrough, J.N. Arnold Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha Science 330 2010 827 830